Starpharma organizacji EV/Sales
Jaka jest wartość EV/Sales organizacji Starpharma?
Wartość EV/Sales organizacji Starpharma Holdings Limited to 16.89
Jaka jest definicja EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales firm w Health Care sektor na ASX w porównaniu do Starpharma
Czym się zajmuję organizacja Starpharma?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Firmy z ev/sales podobne do Starpharma
- Wartość EV/Sales organizacji Clean Seed Capital to 16.86
- Wartość EV/Sales organizacji Brooks Automation to 16.86
- Wartość EV/Sales organizacji Eiger BioPharmaceuticals Inc to 16.87
- Wartość EV/Sales organizacji Desane to 16.87
- Wartość EV/Sales organizacji Guggenheim Taxbl Muni Bnd & Invtmnt Grd Debt Trst Com Shrs Of benf Int to 16.87
- Wartość EV/Sales organizacji Axon Enterprise Inc to 16.89
- Wartość EV/Sales organizacji Starpharma to 16.89
- Wartość EV/Sales organizacji Western Asset Variable Rate Strategic Fund to 16.90
- Wartość EV/Sales organizacji Champignon Brands to 16.90
- Wartość EV/Sales organizacji Boss Resources to 16.91
- Wartość EV/Sales organizacji Zentalis Pharmaceuticals, Llc to 16.93
- Wartość EV/Sales organizacji Hansa Trust A Shares to 16.93
- Wartość EV/Sales organizacji ASLAN Pharmaceuticals Ltd to 16.94